Back

From stepwise to swift: the rationale for early initiation of combination therapy

29 August 2026 (15:20 - 15:25)
Organised by: Logo
Congress Presentation Part of: A new chapter in lipid control: expanding the therapeutic horizon Drug therapy Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Klaus G Parhofer

Ludwig Maximilians University, Munich (Germany)

5 More presentations in this session

Presentation thumbnail
Setting the stage: the unmet need in high-risk patients
Professor K. Ray (London, GB)
Presentation thumbnail
A new chapter for lipid control: the science
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
A new chapter for lipid control: the evidence
Professor E. Michos (Baltimore, US)
Presentation thumbnail
Envisioning the future of dyslipidaemia management - discussion
Presentation thumbnail
Closing remarks and EBAC evaluation
Professor K. Ray (London, GB)

Access the full session

Session thumbnail
A new chapter in lipid control: expanding the therapeutic horizon

The Event

Event poster

ESC Congress 2026

29 August 2026 15:20 CET
You may be interested in
thumbnail
Congress Presentation
Early use of triple single pill combination: make it a habit
30 August 2025
thumbnail
Congress Presentation
Combination therapy rapidly improves symptoms and quality of life in recently diagnosed angina patients: the COMBINE Angina study
1 September 2025
thumbnail
Congress Presentation
Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry
1 September 2024
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources